Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuraxial Morphine Dosing with QL Block in Cesarean Delivery
NCT04279054Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of morphine in pain (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Outcome of side effects of intervention: pruritus, Outcome of side effects of intervention: nausea and 1 more. Started Sep 2020; status: completed.
02
Drugs
morphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04279054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04279054.